Kenneth I. Strauss, PhD, is an Associate Professor of Translational Science & Molecular Medicine, Michigan State University, Grand Rapids, Michigan who specializes in neurotrauma research.
Education[edit | edit source]
- 1981, A.B., Biochemistry, Occidental College, Los Angeles, California
- 1990, PhD, Molecular Biology & Biotechnology, Hahnemann University, Philadelphia, Pennsylvania
Notable studies[edit | edit source]
- 1995, Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen(Abstract)
Learn more[edit | edit source]
- Michigan State University faculty page
- "UC Receives $1.7 Million to Study Molecular Treatment of Brain Injury"
See also[edit | edit source]
References[edit | edit source]
- Strayer, DR; Carter, W; Strauss, KI; Brodsky, I; Suhadolnik, R; Ablashi, D; Henry, B; Mitchell, WM; Bastien, S; Peterson, D (1995), "Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen", Journal of Chronic Fatigue Syndrome, 1 (1): 35-53
chronic fatigue syndrome (CFS) - A fatigue-based illness. The term CFS was invented invented by the U.S. Centers for Disease Control as an replacement for myalgic encephalomyelitis (ME). Some view CFS as a neurological disease, others use the term for any unexplained long-term fatigue. Sometimes used as a the term as a synonym of myalgic encephalomyelitis, despite the different diagnostic criteria.